{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:55Z","timestamp":1792598575221,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8072","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,7,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sex inequalities in cancer are well documented, but the current limited understanding is hindering advances in precision medicine and therapies<jats:sup>1<\/jats:sup>. Consideration of ethnicity, age and sex is essential for the management of cancer patients because they underlie important differences in both incidence and response to treatment<jats:sup>2,3<\/jats:sup>. Age-related hormone production, which is a consistent divergence between the sexes, is underestimated in cancers that are not recognized as being hormone dependent<jats:sup>4\u20136<\/jats:sup>. Here, we show that premenopausal women have increased vulnerability to cancers, and we identify the cell\u2013cell adhesion molecule E-cadherin as a crucial component in the oestrogen response in various cancers, including melanoma. In a mouse model of melanoma, we discovered an oestrogen-sensitizing pathway connecting E-cadherin, \u03b2-catenin, oestrogen receptor-\u03b1 and GRPR that promotes melanoma aggressiveness in women. Inhibiting this pathway by targeting GRPR or oestrogen receptor-\u03b1 reduces metastasis in mice, indicating its therapeutic potential. Our study introduces a concept linking hormone sensitivity and tumour phenotype in which hormones affect cell phenotype and aggressiveness. We have identified an integrated pro-tumour pathway in women and propose that targeting a G-protein-coupled receptor with drugs not commonly used for cancer\u00a0treatment could be more effective in treating E-cadherin-dependent cancers in women. This study emphasizes the importance of sex-specific factors in cancer management and offers hope of improving outcomes in various cancers.<\/jats:p>","DOI":"10.1038\/s41586-025-09111-x","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:02:23Z","timestamp":1749639743000},"page":"801-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin"],"prefix":"10.1038","volume":"643","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8712-895X","authenticated-orcid":false,"given":"J\u00e9r\u00e9my H.","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackie","family":"Aktary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Pouteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wehbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bourban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Decaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Martianov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-1171","authenticated-orcid":false,"given":"Irwin","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine-Laure","family":"Tomasetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Mahuteau-Betzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Vergier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-6107","authenticated-orcid":false,"given":"Lionel","family":"Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-3664","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"9111_CR1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","volume":"29","author":"M Dong","year":"2020","unstructured":"Dong, M. et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol. Biomarkers Prev. 29, 1389\u20131397 (2020).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"9111_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15679-x","volume":"11","author":"Y Ye","year":"2020","unstructured":"Ye, Y. et al. Sex-associated molecular differences for cancer immunotherapy. Nat. Commun. 11, 1779 (2020).","journal-title":"Nat. Commun."},{"key":"9111_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41586-022-04833-8","volume":"606","author":"CP Vellano","year":"2022","unstructured":"Vellano, C. P. et al. Androgen receptor blockade promotes response to BRAF\/MEK-targeted therapy. Nature 606, 797\u2013803 (2022).","journal-title":"Nature"},{"key":"9111_CR4","doi-asserted-by":"publisher","first-page":"106131","DOI":"10.1016\/j.phrs.2022.106131","volume":"177","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y., Wang, X., Liu, Y., Wang, H.-Y. & Xiang, J. The effects of estrogen on targeted cancer therapy drugs. Pharmacol. Res. 177, 106131 (2022).","journal-title":"Pharmacol. Res."},{"key":"9111_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","volume":"11","author":"JB Rubin","year":"2020","unstructured":"Rubin, J. B. et al. Sex differences in cancer mechanisms. Biol. Sex Differ. 11, 17 (2020).","journal-title":"Biol. Sex Differ."},{"key":"9111_CR6","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"9111_CR7","doi-asserted-by":"crossref","unstructured":"Cook, M. B. et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol. Biomarkers Prev. 18, 1174\u20131182 (2009).","DOI":"10.1158\/1055-9965.EPI-08-1118"},{"key":"9111_CR8","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3390\/ijerph18063100","volume":"18","author":"A Metcalfe","year":"2021","unstructured":"Metcalfe, A. et al. Incidence of pregnancy-associated cancer in two Canadian provinces: a population-based study. Int. J. Environ. Res. Public Health 18, 3100 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"9111_CR9","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1471-0528.2012.03475.x","volume":"119","author":"YY Lee","year":"2012","unstructured":"Lee, Y. Y. et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994\u20132008: a population-based linkage study. BJOG 119, 1572\u20131582 (2012).","journal-title":"BJOG"},{"key":"9111_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000360137","volume":"82","author":"E Benyi","year":"2014","unstructured":"Benyi, E. et al. Risks of malignant and non-malignant tumours in tall women treated with high-dose oestrogen during adolescence. Horm. Res. Paediatr. 82, 89\u201396 (2014).","journal-title":"Horm. Res. Paediatr."},{"key":"9111_CR11","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","volume":"65","author":"J Ackermann","year":"2005","unstructured":"Ackermann, J. et al. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 65, 4005\u20134011 (2005).","journal-title":"Cancer Res."},{"key":"9111_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/cancers14030706","volume":"14","author":"JH Raymond","year":"2022","unstructured":"Raymond, J. H., Aktary, Z., Larue, L. & Delmas, V. Targeting GPCRs and their signaling as a therapeutic option in melanoma. Cancers\u00a014, 706 (2022).","journal-title":"Cancers"},{"key":"9111_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28566-4","volume":"13","author":"F Farshidfar","year":"2022","unstructured":"Farshidfar, F. et al. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis. Nat. Commun. 13, 898 (2022).","journal-title":"Nat. Commun."},{"key":"9111_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","volume":"25","author":"F-X Yu","year":"2014","unstructured":"Yu, F.-X. et al. Mutant Gq\/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25, 822\u2013830 (2014).","journal-title":"Cancer Cell"},{"key":"9111_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7683","volume":"6","author":"A Verfaillie","year":"2015","unstructured":"Verfaillie, A. et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat. Commun. 6, 6683 (2015).","journal-title":"Nat. Commun."},{"key":"9111_CR16","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41388-020-1362-9","volume":"39","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis. Oncogene 39, 5267\u20135281 (2020).","journal-title":"Oncogene"},{"key":"9111_CR17","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1177\/1535370220977101","volume":"246","author":"B Zhao","year":"2021","unstructured":"Zhao, B. et al. YAP activation in melanoma contributes to anoikis resistance and metastasis. Exp. Biol. Med. (Maywood) 246, 888\u2013896 (2021).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"9111_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/scbi.2001.0389","volume":"11","author":"S Sommer","year":"2001","unstructured":"Sommer, S. & Fuqua, S. A. Estrogen receptor and breast cancer. Semin. Cancer Biol. 11, 339\u2013352 (2001).","journal-title":"Semin. Cancer Biol."},{"key":"9111_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/bcr309","volume":"3","author":"G Berx","year":"2001","unstructured":"Berx, G. & Van Roy, F. The E-cadherin\/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3, 289\u2013293 (2001).","journal-title":"Breast Cancer Res."},{"key":"9111_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/32918","volume":"392","author":"P Guilford","year":"1998","unstructured":"Guilford, P. et al. E-cadherin germline mutations in familial gastric cancer. Nature 392, 402\u2013405 (1998).","journal-title":"Nature"},{"key":"9111_CR21","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"9111_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano, A. et al. The transcription factor Snail controls epithelial\u2013mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76\u201383 (2000).","journal-title":"Nat. Cell Biol."},{"key":"9111_CR23","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3892\/or.2016.4618","volume":"35","author":"M Venza","year":"2016","unstructured":"Venza, M. et al. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma. Oncol. Rep. 35, 2451\u20132460 (2016).","journal-title":"Oncol. Rep."},{"key":"9111_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2741\/1831","volume":"11","author":"L Larue","year":"2006","unstructured":"Larue, L. & Delmas, V. The WNT\/Beta-catenin pathway in melanoma. Front. Biosci. 11, 733\u2013742 (2006).","journal-title":"Front. Biosci."},{"key":"9111_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jhazmat.2013.06.009","volume":"260","author":"M Avber\u0161ek","year":"2013","unstructured":"Avber\u0161ek, M., \u017degura, B., Filipi\u010d, M., Uranjek-\u017devart, N. & Heath, E. Determination of estrogenic potential in waste water without sample extraction. J. Hazard. Mater. 260, 527\u2013533 (2013).","journal-title":"J. Hazard. Mater."},{"key":"9111_CR26","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/ng.2823","volume":"45","author":"DR Robinson","year":"2013","unstructured":"Robinson, D. R. et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat. Genet. 45, 1446\u20131451 (2013).","journal-title":"Nat. Genet."},{"key":"9111_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2011.08.043","volume":"147","author":"X-Y Liu","year":"2011","unstructured":"Liu, X.-Y. et al. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 147, 447\u2013458 (2011).","journal-title":"Cell"},{"key":"9111_CR28","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1038\/sj.onc.1210029","volume":"26","author":"M Herzig","year":"2007","unstructured":"Herzig, M., Savarese, F., Novatchkova, M., Semb, H. & Christofori, G. Tumor progression induced by the loss of E-cadherin independent of \u03b2-catenin\/Tcf-mediated Wnt signaling. Oncogene 26, 2290\u20132298 (2007).","journal-title":"Oncogene"},{"key":"9111_CR29","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1038\/onc.2008.343","volume":"27","author":"A Jeanes","year":"2008","unstructured":"Jeanes, A., Gottardi, C. J. & Yap, A. S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27, 6920\u20136929 (2008).","journal-title":"Oncogene"},{"key":"9111_CR30","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1242\/dev.122.10.3185","volume":"122","author":"L Larue","year":"1996","unstructured":"Larue, L. et al. A role for cadherins in tissue formation. Development 122, 3185\u20133194 (1996).","journal-title":"Development"},{"key":"9111_CR31","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1038\/sj.onc.1204660","volume":"20","author":"OG Morali","year":"2001","unstructured":"Morali, O. G. et al. IGF-II induces rapid \u03b2-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20, 4942\u20134950 (2001).","journal-title":"Oncogene"},{"key":"9111_CR32","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/sj.emboj.7600136","volume":"23","author":"X Qian","year":"2004","unstructured":"Qian, X., Karpova, T., Sheppard, A. M., McNally, J. & Lowy, D. R. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 23, 1739\u20131748 (2004).","journal-title":"EMBO J."},{"key":"9111_CR33","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1158\/1541-7786.MCR-22-0090","volume":"20","author":"A Elangovan","year":"2022","unstructured":"Elangovan, A. et al. Loss of E-cadherin induces IGF1R activation and reveals a targetable pathway in invasive lobular breast carcinoma. Mol. Cancer Res. 20, 1405\u20131419 (2022).","journal-title":"Mol. Cancer Res."},{"key":"9111_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/cancers14010209","volume":"14","author":"KS Johnson","year":"2022","unstructured":"Johnson, K. S. et al. CTCF expression and dynamic motif accessibility modulates epithelial-mesenchymal gene expression. Cancers\u00a014, 209 (2022).","journal-title":"Cancers"},{"key":"9111_CR35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.tig.2020.07.011","volume":"36","author":"RC Centore","year":"2020","unstructured":"Centore, R. C., Sandoval, G. J., Soares, L. M. M., Kadoch, C. & Chan, H. M. Mammalian SWI\/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies. Trends Genet. 36, 936\u2013950 (2020).","journal-title":"Trends Genet."},{"key":"9111_CR36","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1128\/MCB.23.17.6210-6220.2003","volume":"23","author":"P-W Hsiao","year":"2003","unstructured":"Hsiao, P.-W., Fryer, C. J., Trotter, K. W., Wang, W. & Archer, T. K. BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation. Mol. Cell. Biol. 23, 6210\u20136220 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"9111_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/cells12010110","volume":"12","author":"G Emons","year":"2022","unstructured":"Emons, G. Hormone-dependent cancers: molecular mechanisms and therapeutical implications. Cells 12, 110 (2022).","journal-title":"Cells"},{"key":"9111_CR38","doi-asserted-by":"publisher","first-page":"1155558","DOI":"10.3389\/fphar.2023.1155558","volume":"14","author":"TL Ri\u017ener","year":"2023","unstructured":"Ri\u017ener, T. L. & Romano, A. Targeting the formation of estrogens for treatment of hormone dependent diseases\u2013current status. Front. Pharmacol. 14, 1155558 (2023).","journal-title":"Front. Pharmacol."},{"key":"9111_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/17448069221108965","volume":"18","author":"A Saeki","year":"2022","unstructured":"Saeki, A., Yamanaka, H., Kobayashi, K., Okubo, M. & Noguchi, K. Analgesic effect of gastrin-releasing peptide in the dorsal horn. Mol. Pain 18, 17448069221108965 (2022).","journal-title":"Mol. Pain"},{"key":"9111_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/j.pain.0000000000002677","volume":"164","author":"E Polg\u00e1r","year":"2023","unstructured":"Polg\u00e1r, E. et al. Grpr expression defines a population of superficial dorsal horn vertical cells that have a role in both itch and pain. Pain 164, 149\u2013170 (2023).","journal-title":"Pain"},{"key":"9111_CR41","first-page":"23","volume":"1766","author":"O Patel","year":"2006","unstructured":"Patel, O., Shulkes, A. & Baldwin, G. S. Gastrin-releasing peptide and cancer. Biochim. Biophys. Acta 1766, 23\u201341 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"9111_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10637-006-6886-5","volume":"24","author":"G Schwartsmann","year":"2006","unstructured":"Schwartsmann, G. et al. A phase I trial of the bombesin\/gastrin-releasing peptide (BN\/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest. New Drugs 24, 403\u2013412 (2006).","journal-title":"Invest. New Drugs"},{"key":"9111_CR43","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1073\/pnas.95.6.3188","volume":"95","author":"LL Hampton","year":"1998","unstructured":"Hampton, L. L. et al. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. Proc. Natl Acad. Sci. USA 95, 3188\u20133192 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9111_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41583-021-00526-9","volume":"22","author":"Z-F Chen","year":"2021","unstructured":"Chen, Z.-F. A neuropeptide code for itch. Nat. Rev. Neurosci. 22, 758\u2013776 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"9111_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216230120","volume":"120","author":"S Peng","year":"2023","unstructured":"Peng, S. et al. Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy. Proc. Natl Acad. Sci. USA 120, e2216230120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9111_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41422-022-00743-6","volume":"33","author":"C Li","year":"2023","unstructured":"Li, C. et al. Molecular recognition of itch-associated neuropeptides by bombesin receptors. Cell Res. 33, 184\u2013187 (2023).","journal-title":"Cell Res."},{"key":"9111_CR47","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.7150\/thno.40889","volume":"10","author":"AV Pobbati","year":"2020","unstructured":"Pobbati, A. V. & Hong, W. A combat with the YAP\/TAZ-TEAD oncoproteins for cancer therapy. Theranostics 10, 3622\u20133635 (2020).","journal-title":"Theranostics"},{"key":"9111_CR48","doi-asserted-by":"publisher","first-page":"661718","DOI":"10.3389\/fcell.2021.661718","volume":"9","author":"Z He","year":"2021","unstructured":"He, Z., Li, R. & Jiang, H. Mutations and copy number abnormalities of Hippo pathway components in human cancers. Front. Cell Dev. Biol. 9, 661718 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"9111_CR49","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1021\/acs.jpcb.3c07073","volume":"128","author":"KR Mills","year":"2024","unstructured":"Mills, K. R., Misra, J. & Torabifard, H. Allosteric modulation of the YAP\/TAZ-TEAD interaction by palmitoylation and small-molecule inhibitors. J. Phys. Chem. B 128, 3795\u20133806 (2024).","journal-title":"J. Phys. Chem. B"},{"key":"9111_CR50","doi-asserted-by":"crossref","unstructured":"Deltourbe, L. G. et al. Steroid hormone levels vary with sex, aging, lifestyle, and genetic. Sci. Adv. 11, eadu6094 (2025).","DOI":"10.1126\/sciadv.adu6094"},{"key":"9111_CR51","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"9111_CR52","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow, F. et al. Toward minimal residual disease-directed therapy in melanoma. Cell 174, 843\u2013855 (2018).","journal-title":"Cell"},{"key":"9111_CR53","doi-asserted-by":"publisher","unstructured":"Maag, J. L. V. gganatogram: An R package for modular visualisation of anatograms and tissues based on ggplot2. F1000Research https:\/\/doi.org\/10.12688\/f1000research.16409.2 (2018).","DOI":"10.12688\/f1000research.16409.2"},{"key":"9111_CR54","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1101\/gad.450107","volume":"21","author":"V Delmas","year":"2007","unstructured":"Delmas, V. et al. \u03b2-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21, 2923\u20132935 (2007).","journal-title":"Genes Dev."},{"key":"9111_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0925-4773(02)00090-4","volume":"115","author":"O Boussadia","year":"2002","unstructured":"Boussadia, O., Kutsch, S., Hierholzer, A., Delmas, V. & Kemler, R. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech. Dev. 115, 53\u201362 (2002).","journal-title":"Mech. Dev."},{"key":"9111_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/gene.10197","volume":"36","author":"V Delmas","year":"2003","unstructured":"Delmas, V., Martinozzi, S., Bourgeois, Y., Holzenberger, M. & Larue, L. Cre-mediated recombination in the skin melanocyte lineage. Genesis 36, 73\u201380 (2003).","journal-title":"Genesis"},{"key":"9111_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","volume":"85","author":"M Serrano","year":"1996","unstructured":"Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27\u201337 (1996).","journal-title":"Cell"},{"key":"9111_CR58","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/gene.10036","volume":"32","author":"R Lesche","year":"2002","unstructured":"Lesche, R. et al. Cre\/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32, 148\u2013149 (2002).","journal-title":"Genesis"},{"key":"9111_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23973-5","volume":"12","author":"M Hamm","year":"2021","unstructured":"Hamm, M. et al. BRN2 is a non-canonical melanoma tumor-suppressor. Nat. Commun. 12, 3707 (2021).","journal-title":"Nat. Commun."},{"key":"9111_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9111_CR61","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"9111_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9111_CR63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"9111_CR64","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"9111_CR65","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/pcmr.12807","volume":"32","author":"V Petit","year":"2019","unstructured":"Petit, V. et al. C57BL\/6 congenic mouse NRASQ61K melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo. Pigment Cell Melanoma Res. 32, 829\u2013841 (2019).","journal-title":"Pigment Cell Melanoma Res."},{"key":"9111_CR66","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/BF02616120","volume":"14","author":"R Cailleau","year":"1978","unstructured":"Cailleau, R., Oliv\u00e9, M. & Cruciger, Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911\u2013915 (1978).","journal-title":"In Vitro"},{"key":"9111_CR67","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4049\/jimmunol.153.3.1225","volume":"153","author":"FM Marincola","year":"1994","unstructured":"Marincola, F. M. et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol. 153, 1225\u20131237 (1994).","journal-title":"J. Immunol."},{"key":"9111_CR68","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.celrep.2015.09.037","volume":"13","author":"F Rambow","year":"2015","unstructured":"Rambow, F. et al. New functional signatures for understanding melanoma biology from tumor cell lineage-specific analysis. Cell Rep. 13, 840\u2013853 (2015).","journal-title":"Cell Rep."},{"key":"9111_CR69","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","volume":"51","author":"HD Soule","year":"1973","unstructured":"Soule, H. D., Vazguez, J., Long, A., Albert, S. & Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51, 1409\u20131416 (1973).","journal-title":"J. Natl Cancer Inst."},{"key":"9111_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-9036-8_13","volume":"1930","author":"CS Chirumamilla","year":"2019","unstructured":"Chirumamilla, C. S. et al. Profiling activity of cellular kinases in migrating T-cells. Methods Mol. Biol. 1930, 99\u2013113 (2019).","journal-title":"Methods Mol. Biol."},{"key":"9111_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118\u2013127 (2007).","journal-title":"Biostatistics"},{"key":"9111_CR72","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/bioinformatics\/btl412","volume":"22","author":"ES Motakis","year":"2006","unstructured":"Motakis, E. S., Nason, G. P., Fryzlewicz, P. & Rutter, G. A. Variance stabilization and normalization for one-color microarray data using a data-driven multiscale approach. Bioinformatics 22, 2547\u20132553 (2006).","journal-title":"Bioinformatics"},{"key":"9111_CR73","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkac247","volume":"50","author":"The Galaxy Community.","year":"2022","unstructured":"The Galaxy Community. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 50, W345\u2013W351 (2022).","journal-title":"Nucleic Acids Res."},{"key":"9111_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/bioinformatics\/bty648","volume":"35","author":"B Langmead","year":"2019","unstructured":"Langmead, B., Wilks, C., Antonescu, V. & Charles, R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics 35, 421\u2013432 (2019).","journal-title":"Bioinformatics"},{"key":"9111_CR75","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1210\/me.2011-1311","volume":"26","author":"SC Hewitt","year":"2012","unstructured":"Hewitt, S. C. et al. Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. Mol. Endocrinol. 26, 887\u2013898 (2012).","journal-title":"Mol. Endocrinol."},{"key":"9111_CR76","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.devcel.2012.07.008","volume":"23","author":"J-S Park","year":"2012","unstructured":"Park, J.-S. et al. Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. Dev. Cell 23, 637\u2013651 (2012).","journal-title":"Dev. Cell"},{"key":"9111_CR77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13072-016-0102-4","volume":"9","author":"SK Rhie","year":"2016","unstructured":"Rhie, S. K. et al. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics Chromatin 9, 50 (2016).","journal-title":"Epigenetics Chromatin"},{"key":"9111_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41594-019-0190-5","volume":"26","author":"SJ Nair","year":"2019","unstructured":"Nair, S. J. et al. Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly. Nat. Struct. Mol. Biol. 26, 193\u2013203 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"9111_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"9111_CR80","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.molcel.2015.04.001","volume":"58","author":"C Estar\u00e1s","year":"2015","unstructured":"Estar\u00e1s, C., Benner, C. & Jones, K. A. SMADs and YAP compete to control elongation of \u03b2-catenin:LEF-1-recruited RNAPII during hESC differentiation. Mol. Cell 58, 780\u2013793 (2015).","journal-title":"Mol. Cell"},{"key":"9111_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add5750","volume":"16","author":"J Perovanovic","year":"2023","unstructured":"Perovanovic, J. et al. Oct1 cooperates with the Smad family of transcription factors to promote mesodermal lineage specification. Sci. Signal. 16, eadd5750 (2023).","journal-title":"Sci. Signal."},{"key":"9111_CR82","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2020","unstructured":"Luo, Y. et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Res. 48, D882\u2013D889 (2020).","journal-title":"Nucleic Acids Res."},{"key":"9111_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature14222","volume":"518","author":"JR Dixon","year":"2015","unstructured":"Dixon, J. R. et al. Chromatin architecture reorganization during stem cell differentiation. Nature 518, 331\u2013336 (2015).","journal-title":"Nature"},{"key":"9111_CR84","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41586-025-09353-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09111-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09111-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09111-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:42:14Z","timestamp":1757187734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09111-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":84,"journal-issue":{"issue":"8072","published-print":{"date-parts":[[2025,7,17]]}},"alternative-id":["9111"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09111-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41586-025-09353-9","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-09353-9","URL":"https:\/\/doi.org\/10.1038\/s41586-025-09353-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}